Member Info for Mikesilver

It was clearly stated there will be an update in the week commencing 11th May, stop being so impatient.

I'd love to believe it but we dropped back to less than 70k tests over the last 24 hours. At least we have guaranteed demand and hopefully that increases from PHE and many others

I would have thought there would be an RNS with that amount of ownership in the company if recently bought. I checked the simply wall street website and it says last reported 31 Dec 18 so may well be old and have moved on. Only way to check would be to look through the RNS's for their holdings being sold I think.

Missed out on the massive train if they did sell.

Stick me in for 27p please

No

Based off that revenue to shares for what is essentially a quarter we should be looking at around 360 mil revenue for the year equating to £6 per share with no PE ! Bring on opening

If you were in 2 months ago and still holding a 10% rise is still 30% for you give or take.
Also if you think this share is boring try being in EUA ! We've been halted since February.

I know the hypocrasy in my post but let's just not reply to this sort of crap and let it drop off the message board.

Do you actually read these boards or do you live like a mushroom? Gelboy

Not like we have an OEM with a major pharmaceutical company in America who many believe and very good indicators guide us towards it being thermo fisher

Just because people aren't using your local test centre doesn't mean numbers aren't increasing across the country. Money is paid upon order so I would imagine NCYT has already been paid.

No order was placed with Dyson, no commitment, no guarantee they worked and could be used in a hospital. There never was an order just an ask of UK companies to do what they can incase increased demand was required.

Probably best to go back to keeping your ideas to yourself.

Oh you're such a tease, just get it out for us to see I can't deal with the suspense

Long term for something like the motley fool and other investor articles is 3 years +, so no it isn't a good investment for that time frame but for upto 6 months, perhaps.

3.70 isn't a bad place to be in at. It all depends on how long you plan on staying, if news comes this week of 2019 results and contracts for 8 mill tests worth of orders spanning a period of time over I'd say minimum 5 months then the share price should move up towards 6 or 7. Potentially more than that if orders for a longer period there is no reason why this couldn't see closer to £10 or more.

DYOR and consider if you'd be happy making 10-20% or want 100+

Well I'm not quite in as much as you but it's all relative, another 2.5k in for me. Honest I'll probably be selling that top up if we get over 400p and hold on to my 4k I previously had however when the RNS drops I have no doubt it will be towards 500 anyway.

I'm pretty sure it was posted here a while ago that funds are paid with the order so there is never a backlog of cash. I may be wrong

One has a diagnostic test producing 4 million a month and increasing, the other has a test in development without any approval.

It's a difficult one to say what a fair mcap from a 10mill company to currently 280 mcap given that this will not be around for 2-3 years and it's basically a one off year for most companies involved, potentially just a 6-9 month mass testing frenzy and then numbers will die down so a potential unfair reflection of a full years revenue. I wouldn't mind an increase in mcap at NCYT though to top off.

Hopefully this is similar to ncyt and this is just the start but a lot more people in at an earlier price. I think it was around 2 weeks for FDA approval despite having EUA so Donald may favour Murica first again if anyone is close.

WHO don't seem to be too in favour of antibody tests at the moment having seen infection in previously diagnosed people, here's hoping that changes.

The test will still need to go through FDA approval and be approved everywhere else unless they accept PHE standard trials.

There will be millions of tests required, not everyone in the UK will be tested, one month into all of this and we only have around half a million tests carried out in the UK but I do think they will sell millions if brought to market soon.

£2 per share is potentially realistic dependant on how much it spreads still, if the new cases start to lower etc less antibody testing will be required. However I'd be more than happy with £2 and a couple of weeks on holiday in the Caribbean!

£270 mill would be a share price around £1.65 I think

I cannot see this reaching £3 per share and an Mcap of £450 mill, yes testing will be required for a long time but not long enough to give an mcap at that value. Ncyt is producing 4 million tests and news to increase up to 8 per month and at the moment has an mcap of roughly £270 million.